OMIC LightenUp Face Serum
Natural health product licensed in Canada
- Licence holder
- Mitchell Group USA LLC
- NPN or DIN-HM
- 80137906
- Status
- Active licence
- Licence date
- 20 January 2025
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 1,4-Benzènediol Source : Hydroquinone | 2 % |
Non-medicinal ingredients
Glycérine, Huile de ricin hydrogénée de PEG-40, Métabisulfite de sodium, Propylène glycol, Parfum, Phénoxyéthanol, Acide ascorbique, Sulfite de sodium, Ethylhexylglycérine, Hydroxytoluène butylé, Butylène glycol, Allantoïne, Aqua, Extrait de miel, EDTA de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to gradually lighten age/dark/liver spots, freckles, melasma (the mask of pregnancy), solar lentigines and skin hyperpigmentation. Helps to gradually lighten dark pigment in the skin associated with various skin conditions such as melasma, senile lentigines, and other skin discolourations. Helps to reduce dark spot intensity/hyperpigmentation in cases of mild to moderate facial dyschromia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80137906
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.